Search for: "Williams v. Stevens et al" Results 1 - 20 of 171
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Apr 2024, 9:05 pm by renholding
For many business economists and legal academics, the purpose of any business organization is simply stated: to maximize profits. [read post]
27 Mar 2024, 3:39 pm by Guest Author
Origin and Meaning of the Anti-Power-Concentration Principle In Seila Law v. [read post]
10 Mar 2024, 7:42 am by Dave Maass
Recognizing the worst in government transparency. [read post]
29 Feb 2024, 7:15 pm by Barbara Moreno
Silja Voeneky, et. al., eds., The Cambridge Handbook of Responsible Artificial Intelligence:  Interdisciplinary Perspectives (2022). 82. [read post]
7 Jan 2024, 3:45 am by jonathanturley
– ESTATE OF ASHLI BABBITT) COUNT V Negligent Training (Capitol Police, Capitol Police Board, et al. [read post]
3 Jan 2024, 7:09 am by Norman L. Eisen
Supreme Court, Colorado Republican State Central Committee v. [read post]
16 Jun 2023, 9:30 pm by ernst
We spotted the Brief for American Historical Association et al. as Amici Curiae cited on page 4 (h/t Gautham Rao, Maggie Blackhawk). [read post]
5 May 2023, 9:30 pm by Karen Tani
"Thurgood Marshall et al. on Law Day, 1968. [read post]
25 Feb 2023, 6:50 pm by admin
One of Selikoff’s great achievements, the federalization of worker safety and health in the Williams-Steiger Occupational Safety and Health Act of 1970,[3] languishes because of inadequate resources for enforcement and frivolous efforts to address non-existent problems, such as the lowering of the crystalline silica permissible exposure limit. [read post]
6 Feb 2023, 1:37 pm by Guest Author
In 2002, after a series of accounting scandals involving Enron and WorldCom, Congress swiftly passed the Sarbanes-Oxley Act in an effort to restore investors’ confidence in the market. [read post]
21 Jan 2023, 6:07 pm by admin
Steven Nissen, on the supposed risk of heart attack from the use of rosiglitazone (Avandia).[2] Within days, lawsuits were filed against the manufacturer, GlaxoSmithKline, which ultimately paid over six billion dollars in settlements and costs.[3] Only after the harm of this mass tort was largely complete, the results of a mega-trial, RECORD,[4] became available, and the FDA changed its regulatory stance on rosiglitazone.[5] More recently, on October 17, 2022, the Journal of the National… [read post]